OMEGA HEALTHCARE INVESTORS (OHI) Company Report

Omega Healthcare Investors, Inc. entered into a new "at-the-market" equity offering sales agreement on November 3, 2025.
This agreement allows for the issuance and sale of common stock with an aggregate gross sales price not to exceed $2,000,000,000.
The new agreement replaces a prior "at the market" equity offering sales agreement dated September 6, 2024.
Sales Agents and Forward Sellers will receive compensation not exceeding 2.0% of the gross sales price.
The company continues to meet the requirements for qualification and taxation as a REIT.

Nov 3, 2025, 10:07 PM

8-K

Omega Reports Q3 2025 Financial Results and Updates Investment Strategy

OHI

Earnings

Guidance Update

New Projects/Investments

Omega (OHI) reported Q3 2025 revenue of $312 million and adjusted FFO of $0.79 per share, and raised its full-year adjusted FFO guidance to a range of $3.08 to $3.10 per share.
The company made over $978 million in total new investments through October 2025, including $151 million in Q3 2025, and is expanding its capital allocation strategy to include joint ventures, minority interests, and RIDEA-like structures for higher returns.
A notable new investment is the acquisition of a 49% equity interest in a portfolio of 64 healthcare facilities for $222 million and a planned $93 million investment for a 9.9% equity ownership interest in SABR Healthcare Holdings' operating company, expected to close in January 2026.
Omega's balance sheet remains strong with $737 million in cash at quarter-end, a new $2.3 billion credit facility, and the repayment of $600 million in senior unsecured notes.
The Genesis bankruptcy process is anticipated to conclude in Q1 or Q2 2026, with Genesis continuing to pay full contractual rent and Omega having fully funded its $8 million debtor-in-possession financing.

Oct 31, 2025, 2:00 PM

Transcript

Omega Healthcare Investors Reports Strong Q3 2025 Results and Raises Full-Year AFFO Guidance

OHI

Earnings

Guidance Update

New Projects/Investments

Omega Healthcare Investors reported Q3 2025 adjusted FFO of $0.79 per share and FAD of $0.75 per share, with revenue increasing to $312 million from $276 million in Q3 2024.
The company raised and narrowed its 2025 AFFO guidance to $3.08 to $3.10 per share, projecting 8% year-over-year AFFO growth at the midpoint.
Portfolio performance showed improvement, with trailing 12-month operator EBITDA coverage increasing to 1.55 times as of June 30, 2025, and the below-one-times rent coverage dropping to 4.3% of total rent.
Omega completed $151 million in new investments during Q3 2025 and, subsequent to quarter-end, invested $222 million for a 49% equity interest in a SABR Healthcare joint venture, with an additional $93 million planned for a 9.9% equity stake in SABR Healthcare Holdings.
The company's balance sheet remains robust, ending Q3 2025 with $737 million in cash, a fixed charge coverage ratio of 5.1 times, and leverage reduced to 3.59 times, supported by a new $2.3 billion credit facility and the repayment of $600 million in senior unsecured notes.

Oct 31, 2025, 2:00 PM

Transcript

Omega Healthcare Investors Reports Strong Q3 2025 Results and Raises Full-Year Guidance

OHI

Earnings

Guidance Update

New Projects/Investments

Omega Healthcare Investors reported Q3 2025 adjusted FFO of $0.79 per share and FAD of $0.75 per share, driven by $312 million in revenue, up from $276 million in Q3 2024.
The company raised and narrowed its 2025 AFFO guidance to $3.08-$3.10 per share, with the midpoint reflecting 8% year-over-year growth.
OHI made over $978 million in new investments through October 2025, including a significant $222 million investment for a 49% equity interest in a real estate joint venture with SABR Healthcare and a planned $93 million investment for a 9.9% equity ownership in SABR's operating company, expected to close in January 2026.
The balance sheet remains strong, with $737 million in cash at quarter-end, a fixed charge coverage ratio of 5.1x, and leverage reduced to 3.59x.

Oct 31, 2025, 2:00 PM

Transcript

Omega Healthcare Investors Reports Strong Q3 2025 Results and Raises Full-Year Guidance

OHI

Earnings

Guidance Update

New Projects/Investments

Omega Healthcare Investors, Inc. reported net income of $185 million, or $0.59 per diluted share, and Adjusted FFO of $243 million, or $0.79 per diluted share, for the third quarter of 2025.
The company completed approximately $151 million in new investments during Q3 2025 and acquired a 49% equity interest in a joint venture with Saber Healthcare Holdings for $222 million in October 2025.
Omega closed a new $2.3 billion unsecured credit facility, extended a $428.5 million term loan, and repaid $600 million of senior unsecured notes in October 2025.
The company increased its full-year 2025 Adjusted FFO guidance to between $3.08 and $3.10 per diluted share, up from the previous range of $3.04 to $3.07 per diluted share.

Oct 30, 2025, 8:16 PM

8-K

Omega Reports Strong Q3 2025 Results and Raises Full Year Guidance

OHI

Earnings

Guidance Update

New Projects/Investments

Omega Healthcare Investors reported strong third quarter 2025 results, with net income of $185 million ($0.59 per diluted share) and Adjusted FFO of $243 million ($0.79 per diluted share), both showing significant increases compared to Q3 2024.
The company increased its full year 2025 Adjusted FFO guidance to between $3.08 and $3.10 per diluted share, up from the previous range of $3.04 to $3.07 per diluted share.
Omega completed approximately $978 million in new investments year-to-date, including $151 million in Q3 2025 and a $222 million joint venture in October 2025.
The company closed a new $2.3 billion unsecured credit facility and repaid $600 million of senior unsecured notes on October 15, 2025.
A quarterly cash dividend of $0.67 per share was declared on October 24, 2025.

Oct 30, 2025, 8:15 PM

Press Release

Omega Healthcare Investors closes new $2.30 billion credit facility and amends term loan

OHI

Debt Issuance

New Projects/Investments

Omega Healthcare Investors, Inc. (OHI) closed a new $2.30 billion senior unsecured credit facility on September 30, 2025.
This new facility consists of a four-year $2.0 billion senior unsecured revolving credit facility and a three-year $300.0 million senior unsecured delayed draw term loan facility, replacing Omega's previous $1.45 billion senior unsecured revolving credit facility.
The company also amended its $428.5 million senior unsecured term loan facility, which included a 35 basis point reduction in interest rate margins.
Omega expects to use the Credit Facility for refinancing existing indebtedness, financing acquisitions, and funding working capital, capital expenditures, and other general corporate purposes.
The new Credit Facility includes an "accordion feature" that permits the company to expand its borrowing capacity to an aggregate of not more than $3.0 billion.

Oct 1, 2025, 2:23 PM

8-K

Omega Healthcare Investors Announces Redemption of Senior Notes

OHI

Omega Healthcare Investors, Inc. (OHI) announced it will redeem all of its outstanding $600,000,000 aggregate principal amount of 5.250% Senior Notes due 2026.
The redemption date is set for October 15, 2025, at a price of 100% of their principal amount, plus accrued and unpaid interest.
An irrevocable notice of redemption was mailed to record holders on September 15, 2025.

Sep 15, 2025, 8:18 PM

8-K

Omega Healthcare Investors Announces Redemption of Senior Notes

OHI

Omega Healthcare Investors, Inc. announced the redemption of all its outstanding $600,000,000 aggregate principal amount of 5.250% Senior Notes due 2026.
The redemption will occur on October 15, 2025, at a price of 100% of their principal amount, plus accrued and unpaid interest.
An irrevocable notice of redemption was mailed to record holders on September 15, 2025.

Sep 15, 2025, 8:15 PM

Press Release

Earnings Transcripts

Quarterly earnings call transcripts for OMEGA HEALTHCARE INVESTORS.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did C. Taylor Pickett say about margins?What are OMEGA HEALTHCARE INVESTORS's strategic priorities?How is OMEGA HEALTHCARE INVESTORS positioned vs competitors?How did OMEGA HEALTHCARE INVESTORS do last quarter?

Let Fintool AI Agent track OMEGA HEALTHCARE INVESTORS's earnings for you

Get instant analysis when filings drop